Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3424, ahead of Dianthus Therapeutics (2341) and CG Oncology (1819). Figures as of 19 Nov 2026, 14:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3424
- Median
- 4.3
- Combined market value
- CZK 201.96T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3424 | CZK 628.6B | CZK 867.54 | 0.79% up | 91% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2341 | CZK 105.9B | CZK 1,881.15 | 0.79% up | 108% up | ||
| 3 | CG OncologyCGON · Health Care | 1819 | CZK 163.3B | CZK 1,828.37 | 2.84% up | 97% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1128 | CZK 88B | CZK 906.74 | 1.52% up | 18% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 267 | CZK 232.4B | CZK 2,721.66 | 1.10% up | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 180 | CZK 184.2B | CZK 2,822.11 | 0.14% down | 51% up | ||
| 7 | CytokineticsCYTK · Health Care | 82.2 | CZK 160.9B | CZK 1,155.09 | 1.28% up | 19% down | ||
| 8 | ImmunityBioIBRX · Health Care | 63.7 | CZK 160.3B | CZK 150.64 | 1.17% up | 232% up | ||
| 9 | InsmedINSM · Health Care | 43.3 | CZK 583.9B | CZK 2,661.66 | 0.03% down | 40% down | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | 43.3 | CZK 182.5B | CZK 2,631.88 | 0.52% down | 18% up | ||
| 11 | ModernaMRNA · Health Care | 41.8 | CZK 1.81T | CZK 4,466.20 | 2.12% up | 780% up | ||
| 12 | GRAILGRAL · Health Care | 33.1 | CZK 108.1B | CZK 2,405.08 | 5.99% up | 19% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.6 | CZK 341B | CZK 1,750.36 | 0.96% up | 21% up | ||
| 14 | WatersWAT · Health Care | 29.3 | CZK 2.06T | CZK 10,482.84 | 1.20% up | 23% up | ||
| 15 | GlaukosGKOS · Health Care | 27.3 | CZK 307.6B | CZK 5,195.64 | 0.30% up | 145% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.3 | CZK 209.9B | CZK 7,083.68 | 1.08% up | 54% up | ||
| 17 | HeartflowHTFL · Health Care | 23.4 | CZK 91.6B | CZK 1,042.08 | 2.18% up | 66% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | CZK 132.8B | CZK 6,640.31 | 0.03% up | 50% up | ||
| 19 | Ascendis PharmaASND · Health Care | 22.2 | CZK 395.1B | CZK 6,022.70 | 0.25% up | 29% up | ||
| 20 | Twist BioscienceTWST · Health Care | 21.6 | CZK 181B | CZK 2,655.32 | 2.69% up | 346% up | ||
| 21 | Guardant HealthGH · Health Care | 21.4 | CZK 467.9B | CZK 3,458.28 | 7.21% up | 45% up | ||
| 22 | NateraNTRA · Health Care | 18.8 | CZK 963.2B | CZK 6,642.75 | 3.25% up | 28% up | ||
| 23 | Eli LillyLLY · Health Care | 18.8 | CZK 27.21T | CZK 30,549.11 | 0.56% down | 33% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 17.1 | CZK 105.3B | CZK 650.72 | 2.88% up | 74% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.6 | CZK 876.9B | CZK 1,525.01 | 0.07% down | 79% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 16.3 | CZK 222.7B | CZK 1,473.12 | 0.25% up | 117% up | ||
| 27 | RepligenRGEN · Health Care | 15.5 | CZK 253.6B | CZK 3,966.54 | 3.36% up | 12% up | ||
| 28 | Intuitive SurgicalISRG · Health Care | 14.6 | CZK 3.27T | CZK 9,445.20 | 0.96% up | 24% down | ||
| 29 | BillionToOneBLLN · Health Care | 14.6 | CZK 98.7B | CZK 2,066.83 | 1.59% up | 4% down | ||
| 30 | argenxARGX · Health Care | 14.3 | CZK 1.32T | CZK 20,963.01 | 0.21% up | 2% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.8 | CZK 1.22T | CZK 15,490.13 | 0.21% down | 1% up | ||
| 32 | 10x GenomicsTXG · Health Care | 12.4 | CZK 177.4B | CZK 1,348.55 | 6.33% up | 247% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | 11.7 | CZK 135.1B | CZK 2,070.17 | 0.71% up | 34% up | ||
| 34 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | CZK 3.02T | CZK 11,921.51 | 0.00% down | 27% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.2 | CZK 159.1B | CZK 3,024.24 | 1.55% up | 6% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.2 | CZK 167.9B | CZK 2,137.50 | 1.19% up | 129% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 10.0 | CZK 1.34T | CZK 2,338.63 | 0.03% up | 25% up | ||
| 38 | Madrigal PharmaceuticalsMDGL · Health Care | 10.0 | CZK 212B | CZK 9,126.73 | 3.16% up | 27% down | ||
| 39 | Travere TherapeuticsTVTX · Health Care | 9.9 | CZK 107.9B | CZK 1,123.87 | 0.66% up | 45% up | ||
| 40 | Corcept TherapeuticsCORT · Health Care | 9.9 | CZK 166.8B | CZK 1,524.12 | 1.17% up | 10% down | ||
| 41 | Bio-TechneTECH · Health Care | 9.4 | CZK 254B | CZK 1,616.80 | 0.00% | 24% up | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.2 | CZK 627.6B | CZK 9,008.72 | 0.33% up | 57% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | CZK 280.8B | CZK 7,125.24 | 0.03% up | 15% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.7 | CZK 1.03T | CZK 8,996.83 | 0.30% up | 16% up | ||
| 45 | GenmabGMAB · Health Care | 8.6 | CZK 713.6B | CZK 1,157.31 | 2.17% up | 70% up | ||
| 46 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | CZK 771.2B | CZK 38,771.10 | 0.40% up | 24% up | ||
| 47 | AbbVieABBV · Health Care | 8.2 | CZK 11.18T | CZK 6,322.73 | 0.51% down | 25% up | ||
| 48 | United TherapeuticsUTHR · Health Care | 7.7 | CZK 546.3B | CZK 12,827.03 | 0.03% down | 22% up | ||
| 49 | Halozyme TherapeuticsHALO · Health Care | 7.7 | CZK 238.5B | CZK 2,091.95 | 1.74% down | 39% up | ||
| 50 | IlluminaILMN · Health Care | 7.5 | CZK 722.7B | CZK 4,779.49 | 2.40% up | 76% up | ||
| 51 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | CZK 136.2B | CZK 963.30 | 0.55% up | 13% up | ||
| 52 | Agilent TechnologiesA · Health Care | 7.3 | CZK 1.13T | CZK 4,000.32 | 1.55% up | 22% up | ||
| 53 | ExelixisEXEL · Health Care | 7.2 | CZK 371.1B | CZK 1,520.79 | 0.21% up | 63% up | ||
| 54 | Medpace HoldingsMEDP · Health Care | 7.2 | CZK 404.4B | CZK 14,456.05 | 0.56% up | 10% up | ||
| 55 | Caris Life SciencesCAI · Health Care | 7.2 | CZK 129.5B | CZK 451.70 | 4.23% up | 19% down | ||
| 56 | Gilead SciencesGILD · Health Care | 7.1 | CZK 4.65T | CZK 3,751.41 | 0.11% down | 35% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 6.9 | CZK 14.44T | CZK 5,998.92 | 1.02% down | 34% up | ||
| 58 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | CZK 2.16T | CZK 20,892.78 | 0.57% down | 28% up | ||
| 59 | DexComDXCM · Health Care | 6.6 | CZK 683.8B | CZK 1,833.59 | 0.02% down | 41% up | ||
| 60 | DanaherDHR · Health Care | 6.6 | CZK 3.6T | CZK 5,114.96 | 0.74% up | 3% up | ||
| 61 | BioNTechBNTX · Health Care | 6.6 | CZK 463.6B | CZK 1,869.71 | 1.04% up | 14% down | ||
| 62 | AmgenAMGN · Health Care | 6.5 | CZK 5.34T | CZK 9,863.01 | 0.02% down | 32% up | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | CZK 179.4B | CZK 2,168.40 | 0.27% up | 3% down | ||
| 64 | RevvityRVTY · Health Care | 6.0 | CZK 382.5B | CZK 3,426.39 | 1.09% up | 62% up | ||
| 65 | ResMedRMD · Health Care | 6.0 | CZK 756.3B | CZK 5,376.65 | 0.28% down | 1% down | ||
| 66 | Thermo Fisher ScientificTMO · Health Care | 5.8 | CZK 5.78T | CZK 15,599.36 | 1.31% up | 21% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.8 | CZK 366.6B | CZK 3,622.07 | 0.07% up | 17% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.5 | CZK 452.4B | CZK 3,377.83 | 1.73% up | 66% down | ||
| 69 | AlkermesALKS · Health Care | 5.3 | CZK 174.5B | CZK 1,038.42 | 0.27% down | 66% up | ||
| 70 | NovartisNVS · Health Care | 5.3 | CZK 6.41T | CZK 3,392.94 | 1.67% down | 25% up | ||
| 71 | Merck & CoMRK · Health Care | 5.2 | CZK 7.53T | CZK 3,056.25 | 0.17% down | 45% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | CZK 228.3B | CZK 1,105.42 | 0.36% up | 9% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | CZK 102.9B | CZK 617.58 | 1.46% up | 63% down | ||
| 74 | StrykerSYK · Health Care | 4.8 | CZK 2.67T | CZK 7,011.67 | 0.82% down | 12% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.7 | CZK 6.12T | CZK 3,946.98 | 0.65% down | 1% up | ||
| 76 | IncyteINCY · Health Care | 4.7 | CZK 534.4B | CZK 2,621.99 | 0.15% up | 16% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | CZK 148.2B | CZK 2,265.74 | 0.05% down | 90% up | ||
| 78 | HaemoneticsHAE · Health Care | 4.2 | CZK 125.5B | CZK 2,754.89 | 0.85% up | 64% up | ||
| 79 | STERISSTE · Health Care | 4.2 | CZK 554.5B | CZK 5,710.46 | 1.03% down | 1% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | CZK 4.04T | CZK 2,333.52 | 0.49% up | 16% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 4.0 | CZK 360.5B | CZK 7,524.05 | 1.64% up | 106% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.9 | CZK 226.7B | CZK 8,430.01 | 2.47% up | 22% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.8 | CZK 3.89T | CZK 882.96 | 0.71% up | 17% down | ||
| 84 | LivaNovaLIVN · Health Care | 3.8 | CZK 115.9B | CZK 2,104.50 | 0.16% up | 77% up | ||
| 85 | LifeStance Health GroupLFST · Health Care | 3.7 | CZK 118.2B | CZK 310.88 | 1.59% up | 123% up | ||
| 86 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | CZK 352.5B | CZK 5,491.55 | 0.27% down | 41% up | ||
| 87 | BiogenBIIB · Health Care | 3.7 | CZK 816.9B | CZK 5,526.44 | 1.09% down | 49% up | ||
| 88 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | CZK 263.5B | CZK 1,360.33 | 0.36% down | 17% up | ||
| 89 | MSA SafetyMSA · Health Care | 3.7 | CZK 153B | CZK 3,971.87 | 0.69% up | 16% up | ||
| 90 | ZoetisZTS · Health Care | 3.6 | CZK 760.2B | CZK 1,871.04 | 1.61% down | 26% down | ||
| 91 | InsuletPODD · Health Care | 3.6 | CZK 215.2B | CZK 3,101.80 | 0.29% down | 55% down | ||
| 92 | MedtronicMDT · Health Care | 3.6 | CZK 2.87T | CZK 2,243.51 | 0.26% up | 1% up | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | CZK 277.2B | CZK 332.47 | 0.13% down | 8% up | ||
| 94 | AlconALC · Health Care | 3.5 | CZK 800B | CZK 1,665.36 | 0.39% down | 0% up | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.3 | CZK 112.2B | CZK 1,872.37 | 1.96% down | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | CZK 145.9B | CZK 3,678.18 | 0.29% down | 58% up | ||
| 97 | Globus MedicalGMED · Health Care | 3.2 | CZK 207.5B | CZK 1,566.32 | 0.07% down | 14% down | ||
| 98 | Boston ScientificBSX · Health Care | 3.2 | CZK 1.41T | CZK 975.63 | 0.55% up | 55% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.1 | CZK 70B | CZK 361.14 | 0.00% | 41% down | ||
| 100 | PTC TherapeuticsPTCT · Health Care | 2.9 | CZK 111.9B | CZK 1,339.66 | 0.08% up | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2240 CZK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3424), Dianthus Therapeutics (2341) and CG Oncology (1819) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 14:33 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of CZK 201.96T as of 19 Nov 2026, 14:33 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.